*Department of Ophthalmology and Optometry, Christian Doppler Laboratory for Ophthalmic Image Analysis, Medical University of Vienna, Vienna, Austria;
†Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria; and
‡Novartis Pharma AG, Basel, Switzerland.
Reprint requests: Ursula Schmidt-Erfurth, MD, Department of Ophthalmology, Medical University of Vienna Spitalgasse 23, 1090 Vienna, Austria; e-mail: [email protected]
Supported by the Austrian Federal Ministry of Education, Science and Research, the Austrian National Foundation for Research, Technology and Development, and the Christian Doppler Research Association. The OCTAVE study was funded and conducted by Novartis. The funding organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data and preparation of the manuscript. Novartis participated in review and approval of the manuscript and decision to submit for publication.
Presented as a poster at the Annual Meeting of the Association of Research in Vision and Ophthalmology 2019, Vancouver, BC, Canada, May 29, 2019.
J. W. Seaman III: employee of Novartis; S. M. Waldstein: Bayer, Genentech: Grant support; Novartis: Consultancy; U. Schmidt-Erfurth: Boehringer Ingelheim, Novartis, Roche, Genentech: Consultancy.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.retinajournal.com).
